Cervical Cancer Screening: Most Women Still Prefer Clinics, Study Finds

February 6, 2026 – American women now have a new option for cervical cancer screening: at-home self-collection tools. However, a recent study reveals that the majority – over 60% – still prefer traditional, in-clinic screenings performed by a healthcare professional.

The findings, published today in JAMA Network Open, come from research conducted by The University of Texas MD Anderson Cancer Center. Researchers surveyed over 2,300 women eligible for cervical cancer screening to gauge their preferences regarding this evolving landscape of preventative care. While the FDA approved the first home-based self-sampling device in May, the study indicates that a significant portion of the population remains comfortable with, and prefers, the established clinical method.

“Home-based self-sampling has the potential to remove many of the barriers women face when it comes to cervical cancer screening,” explains Dr. Sanjay Shete, Ph.D., deputy division head of Cancer Prevention and Population Sciences at MD Anderson. “By expanding screening options and pairing them with targeted education, One can empower more women to participate in screening in a way that fits their lives.”

Understanding the Preference for In-Clinic Screening

The study found that 60.8% of women favored in-clinic screenings. Just 20.4% expressed a preference for at-home self-sampling, while 18.8% remained unsure. This preference isn’t uniform across all demographics. The research highlighted important differences based on race, socioeconomic status, and experiences with the healthcare system.

Notably, Black women were less likely to prefer at-home self-sampling compared to white women. This suggests that cultural factors, historical experiences, or systemic issues may contribute to this disparity. Women with lower incomes and those who reported a lack of trust in the healthcare system were also more likely to be uncertain about which screening method to choose.

Why At-Home Screening Might Appeal to Some

Despite the overall preference for in-clinic visits, the study identified key reasons why some women might opt for at-home self-sampling. Privacy was the most frequently cited benefit, with 54.9% of respondents indicating it was a significant factor. Time constraints (35.1%) and a desire to avoid embarrassment (33.4%) were also commonly mentioned.

These findings are particularly relevant in light of decreased annual screening coverage observed since the COVID-19 pandemic. Experts believe that offering more accessible options, like at-home kits, could help improve screening rates, especially among those who face barriers to traditional healthcare access.

The Role of Targeted Education and Policy Changes

The researchers emphasize the importance of pairing expanded screening options with targeted education. Addressing concerns about trust, providing clear instructions, and highlighting the benefits of both in-clinic and at-home methods could help increase participation across all demographics.

“Major public health and medical organizations should consider updating their recommendations to include home-based self-sampling,” suggests Dr. Joël Fokom Domgue, M.D., senior researcher of Epidemiology and a co-author of the study. “This policy shift could play a critical role in reducing screening inequities and improving uptake among populations that have historically been underserved.”

Study Methodology and Limitations

The study was based on data from the 2024 Health Information National Trends Survey (HINTS), a nationally representative survey of U.S. Adults. The analysis included women aged 21 to 65 who were eligible for cervical cancer screening according to U.S. Preventive Services Task Force guidelines.

Researchers acknowledge certain limitations. The study’s cross-sectional design provides a snapshot in time, and the HINTS survey did not collect data on prior screening history. The FDA had not yet approved self-collection tools at the time the HINTS survey was conducted, potentially impacting respondents’ familiarity with the option.

Looking Ahead

The introduction of at-home cervical cancer screening represents a significant advancement in preventative healthcare. While the majority of American women currently prefer in-clinic screenings, the availability of alternative options, coupled with targeted education and policy changes, could help bridge gaps in access and improve screening rates for all. Continued research and monitoring will be crucial to understanding the long-term impact of these evolving screening methods and ensuring equitable access to care.